Showing results (21-30 of 33) with videos related to
Sort By:
Pageof 4
Molecular Carcinogenesis|June 7, 2005
Characterization of medroxyprogesterone and DMBA-induced multilineage mammary tumors by gene expression profilingYuzhi Yin, Renkui Bai, Robert G Russell, et al.The Journal of Allergy and Clinical Immunology. Global|August 16, 2024
Increased expression of formyl peptide receptor-1 by basophils from patients with mastocytosisYuzhi Yin, Jenny Min Li, Dean D Metcalfe, et al.Frontiers in Immunology|April 13, 2018
Targeting Sphingosine Kinase Isoforms Effectively Reduces Growth and Survival of Neoplastic Mast Cells With D816V-KITGeethani Bandara, Rosa Muñoz-Cano, Araceli Tobío, et al.Proceedings of the National Academy of Sciences of the United States of America|November 23, 2016
Exon skipping of FcεRIβ eliminates expression of the high-affinity IgE receptor in mast cells with therapeutic potential for allergyGlenn Cruse, Yuzhi Yin, Tomoki Fukuyama, et al.Plos One|February 8, 2011
PPARδ activation acts cooperatively with 3-phosphoinositide-dependent protein kinase-1 to enhance mammary tumorigenesisClaire B Pollock, Yuzhi Yin, Hongyan Yuan, et al.Journal of Clinical & Cellular Immunology|November 19, 2014
Inflammatory Markers of the Systemic Capillary Leak Syndrome (Clarkson Disease)Zhihui Xie, Eunice Chan, Yuzhi Yin, et al.Cancer Research|May 4, 2005
Peroxisome proliferator-activated receptor delta and gamma agonists differentially alter tumor differentiation and progression during mammary carcinogenesisYuzhi Yin, Robert G Russell, Luis E Dettin, et al.Journal of Leukocyte Biology|January 24, 2018
Adrenomedullin surges are linked to acute episodes of the systemic capillary leak syndrome (Clarkson disease)Zhihui Xie, Wei-Sheng Chen, Yuzhi Yin, et al.Human Gene Therapy|February 28, 2002
Self-assembly of a virus-mimicking nanostructure system for efficient tumor-targeted gene deliveryLiang Xu, Peter Frederik, Kathleen F Pirollo, et al.Frontiers in Oncology|May 16, 2022
Human Tumor Targeted Cytotoxic Mast Cells for Cancer ImmunotherapyMohammad Fereydouni, Elnaz Ahani, Parth Desai, et al.Pageof 4